BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers

Summary

This is a randomized, double-blind, placebo-controlled, sequential dose escalation study in diabetic subjects with a diabetic lower leg or foot ulcer. All subjects will receive standard-of-care ulcer treatment from screening through the last study visit.

Timeline

Start

2018-03-28

Primary completion

2021-12-01

Completion

2023-12-31

Drugs

Indications